Characterization of cholesterol homeostasis in telomeraseimmortalized tangier disease fibroblasts reveals marked phenotype variability

Journal of Biological Chemistry

Volumn 288, Issue 52, 2013, Pages 36936-36947

  Kannenberg, Frank ^a   Gorzelniak, Kerstin ^b   Jäger, Kathrin ^c   Fobker, Manfred ^a   Rust, Stephan ^a   Repa, Joyce ^d   Roth, Mike ^d   Björkhem, Ingemar ^e   Walter, Michael ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Unfallkrankenhaus Marzahn   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL HOMEOSTASIS; DOWN-REGULATION; IN-DEGREE; IN-VIVO; MOLECULAR DEFECTS; TANGIER DISEASE;

BIOCHEMISTRY; CELL CULTURE; FIBROBLASTS;

CHOLESTEROL;

ABC TRANSPORTER A1; CHOLESTEROL; TELOMERASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CELL IMMORTALIZATION; CELLULAR DISTRIBUTION; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL SYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROBLAST; GENE MUTATION; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TANGIER DISEASE;

EID: 84891380201     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.500256     Document Type: Article

References (51)

1. Rust, S., Walter, M., Funke, H., von Eckardstein, A., Cullen, P., Kroes, H. Y., Hordijk, R., Geisel, J., Kastelein, J., Molhuizen, H. O., Schreiner, M., Mischke, A., Hahmann H. W., and Assmann, G. (1998) Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat. Genet. 20, 96-98
2. Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J. C., Deleuze, J. F., Brewer, H. B., Duverger, N., Denèfle, P., and Assmann, G. (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22, 352-355
3. Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Ozcürümez, M., Kaminski, W. E., Hahmann, H. W., Oette, K., Rothe, G., Aslanidis, C., Lackner, K. J., and Schmitz, G. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22, 347-351
4. Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L. H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O., Loubser, O., Ouelette, B. F., Fichter, K., Ashbourne-Excoffon, K. J., Sensen, C. W., Scherer, S., Mott, S., Denis, M., Martindale, D., Frohlich, J., Morgan, K., Koop, B., Pimstone, S., Kastelein, J. J., Genest, J., Jr., and Hayden, M. R. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22, 336-345
5. Walter M., Forsyth N. R., Wright W. E., Shay J. W., and Roth M. G. (2004) The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1- independent cholesterol efflux pathway. J. Biol. Chem. 279, 20866-20873
6. Assmann, G., von Eckardstein, A., and Brewer, H. B., Jr. (1995) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. A., Beaudet, A. L., Sly, W. S., and Valle, D., Eds) 7th Ed., pp. 2053-2072, McGraw-Hill, New York
7. Serfaty-Lacrosniere, C., Civeira, F., Lanzberg, A., Isaia, P., Berg, J., Janus, E. D., Smith, M. P., Jr., Pritchard, P. H., Frohlich, J., and Lees, R. S. (1994) Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107, 85-98
8. Walter, M., Kerber, S., Fechtrup, C., Seedorf, U., Breithardt, G., and Assmann, G. (1994) Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency. Atherosclerosis 110, 203-208
9. Rader, D. J., Ikewaki, K., Duverger, N., Feuerstein, I., Zech, L., Connor, W., and Brewer, H. B., Jr. (1993) Very low high-density lipoproteins without coronary atherosclerosis. Lancet 342, 1455-1458
10. Walter, M., Gerdes, U., Seedorf, U., and Assmann, G. (1994) The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem. Biophys. Res. Commun. 205, 850-856
11. Francis, G. A., Knopp, R. H., and Oram, J. F. (1995) Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J. Clin. Invest. 96, 78-87
12. Rogler, G., Trümbach, B., Klima, B., Lackner, K. J., and Schmitz G. (1995) HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 15, 683-690
13. Ouellette, M. M., McDaniel, L. D., Wright, W. E., Shay, J. W., and Schultz, R. A. (2000) The establishment of telomerase-immortalized cell lines representing human chromosome instability syndromes. Hum. Mol. Genet. 9, 403-411
14. Drobnik, W., Liebisch, G., Biederer, C., Trumbach, B., Rogler, G., Müller, P., and Schmitz, G. (1999) Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 19, 28-38
15. Utech, M., Höbbel, G., Rust, S., Reinecke, H., Assmann, G., and Walter, M. (2001) Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem. Biophys. Res. Commun. 280, 229-236
16. Havel, R. J., Eder, H. A., and Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353
17. Walter, M., Reinecke, H., Gerdes, U., Nofer, J.-R., Höbbel, G., Seedorf, U., and Assmann, G. (1996) Defective regulation of phosphatidylcholine- specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J. Clin. Invest. 98, 2315-2323
18. Morgenstern, J. P., and Land, H. (1990) Advanced mammalian gene transfer. High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596
19. Steinert, S., Shay, J. W., and Wright, W. E. (2000) Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem. Biophys. Res. Commun. 273, 1095-1098
20. Walter, M., Reinecke, H., Nofer, J.-R., Seedorf, U., and Assmann, G. (1995) HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 15, 1975-1986
21. Engel, T., Kannenberg, F., Fobker, M., Nofer, J. R., Bode, G., Lueken, A., Assmann, G., and Seedorf, U. (2007) Expression of ATP binding cassettetransporter ABCG1 prevents cell death by transporting cytotoxic 7α-hydroxycholesterol. FEBS Lett. 581, 1673-1680
22. Cullen, P., Tegelkamp, K., Fobker, M., Kannenberg, F., and Assmann, G. (1997) Measuring cholesterol in macrophages. Comparison of high-performance liquid chromatography and gas-liquid chromatography with enzymatic fluorometry. Anal. Biochem. 251, 39-44
23. Cullen, P., Fobker, M., Tegelkamp, K., Meyer, K., Kannenberg, F., Cignarella, A., Benninghoven, A., and Assmann, G. (1997) An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl ester species by means of secondary ion mass spectrometry. J. Lipid Res. 38, 401-409
24. Klansek, J. J., Yancey, P., St. Clair, R. W., Fischer, R. T., Johnson, W. J., and Glick, J. M. (1995) Cholesterol quantitation by GLC. Artifactual formation of short-chain steryl esters. J. Lipid Res. 36, 2261-2266
25. Tint, G. S., Irons, M., Elias, E. R., Batta, A. K., Frieden, R., Chen, T. S., and Salen, G. (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330, 107-113
26. Arakawa, R., and Yokoyama, S. (2002) Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol proteasemediated degradation. J. Biol. Chem. 277, 22426-22429
27. Frolov, A., Zielinski, S. E., Crowley, J. R., Dudley-Rucker, N., Schaffer, J. E., and Ory, D. S. (2003) NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. J. Biol. Chem. 278, 25517-25525
28. Millard, E. E., Srivastava, K., Traub, L. M., Schaffer, J. E., and Ory, D. S. (2000) Niemann-pick type C1 (NPC1) overexpression alters cellular cholesterol homeostasis. J. Biol. Chem. 275, 38445-38451
29. Björkhem, I., Diczfalusy, U., and Lütjohann, D. (1999) Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10, 161-165
30. Lund, E., Andersson, O., Zhang, J., Babiker, A., Ahlborg, G., Diczfalusy, U., Einarsson, K., Sjövall, J., and Björkhem, I. (1996) Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromb. Vasc. Biol. 16, 208-212
31. Björkhem, I. (2002) Do oxysterols control cholesterol homeostasis? J. Clin. Invest. 110, 725-730
32. Axelson, M., and Larsson, O. (1995) Low density lipoprotein (LDL) cholesterol is converted to 27-hydroxycholesterol in human fibroblasts. Evidence that 27-hydroxycholesterol can be an important intracellular mediator between LDL and the suppression of cholesterol production. J. Biol. Chem. 270, 15102-15110
33. Kandutsch, A. A., and Chen, H. W. (1975) Regulation of sterol synthesis in cultured cells by oxygenated derivatives of cholesterol. J. Cell Physiol. 85, 415-424
34. Esterman, A. L., Baum, H., Javitt, N. B., and Darlington, G. J. (1983) 26- Hydroxycholesterol. Regulation of hydroxymethylglutaryl-CoA reductase activity in Chinese hamster ovary cell culture. J. Lipid Res. 24, 1304-1309
35. Fu, X., Menke, J. G., Chen, Y., Zhou, G., MacNaul, K. L., Wright, S. D., Sparrow, C. P., and Lund, E. G. (2001) 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276, 38378-38387
36. Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., and Mangelsdorf, D. J. (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. 96, 266-271
37. Chang, T. Y., Chang, C. C., Ohgami, N., and Yamauchi, Y. (2006) Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129-157
38. Sato, R., Inoue, J., Kawabe, Y., Kodama, T., Takano, T., and Maeda, M. (1996) Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271, 26461-26464
39. Brown, A. J., and Jessup, W. (1999) Oxysterols and atherosclerosis. Atherosclerosis 142, 1-28
40. Tabas, I. (2002) Cholesterol in health and disease. J. Clin. Invest. 110, 583-590
41. Lund, E., Björkhem, I., Furster, C., and Wikvall, K. (1993) 24-, 25-, and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta 1166, 177-182
42. Lange, Y., Ory, D. S., Ye, J., Lanier, M. H., Hsu, F. F., and Steck, T. L. (2008) Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 283, 1445-1455
43. Wang, Y., Rogers, P. M., Su, C., Varga, G., Stayrook, K. R., and Burris, T. P. (2008) Regulation of cholesterologenesis by the oxysterol receptor, LXRα. J. Biol. Chem. 283, 26332-26339
44. Landau, J. M., Sekowski, A., and Hamm, M. W. (1997) Dietary cholesterol and the activity of stearoyl CoA desaturase in rats. Evidence for an indirect regulatory effect. Biochim. Biophys. Acta 1345, 349-357
45. Repa, J. J., Turley, S. D., Lobaccaro, J. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., and Mangelsdorf, D. J. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529
46. Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J. M., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., and Mangelsdorf, D. J. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev. 14, 2819-2830
47. Amemiya-Kudo, M., Shimano, H., Yoshikawa, T., Yahagi, N., Hasty, A. H., Okazaki, H., Tamura, Y., Shionoiri, F., Iizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Sato, R., Kimura, S., Ishibashi, S., and Yamada, N. (2000) Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. J. Biol. Chem. 275, 31078-31085
48. Forsyth, N. R., Evans, A. P., Shay, J. W., and Wright, W. E. (2003) Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell 2, 235-243
49. Walter, M. (2009) Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1244-1250
50. Oram, J. F., Mendez, A. J., Lymp, J., Kavanagh, T. J., and Halbert, C. L. (1999) Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP. Lack of effect with Tangier disease cells. J. Lipid Res. 40, 1769-1781
51. Björkhem I. (2009) Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res. 50, (suppl.) S213-S218